MSABP Provides High Strength Pharmaceutical Wastewater Treatment Without Sludge Production
Source: Aquarius Technologies Inc.
Click Here To Download:
•Case Study: MSABP Provides High Strength Pharmaceutical Wastewater Treatment Without Sludge Production
By Aquarius Technologies Inc.
The wastewater generated by the pharmaceutical processes employed by Teva Pharmaceutical Industries Ltd. contain COD levels approaching 50,000 mg/l. Treatment required the ability to adapt to a broad array of influent constituents, including high chloride levels and solvents. For this reason, Teva selected the MSABP™ process.
Click Here To Download:
•Case Study: MSABP Provides High Strength Pharmaceutical Wastewater Treatment Without Sludge Production
This website uses cookies to ensure you get the best experience on our website. Learn more